Niacinamide

Niacinamide

SCHEMBL8447047

C[C@@]1(n2cnc3c(N)ncnc32)O[C@H](CO)[C@@H](O)[C@H]1S.NC(=O)c1cccnc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.47
▸ SRC P12931 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ ERBB2 P04626 1/20 0.41
▸ ADORA2A P29274 4/20 0.40
▸ NNMT P40261 3/20 0.40
▸ PI4KA P42356 3/20 0.39
▸ PI4K2B Q8TCG2 3/20 0.39
▸ PI4K2A Q9BTU6 3/20 0.39
▸ PI4KB Q9UBF8 3/20 0.39
▸ ADORA3 P0DMS8 4/20 0.39
▸ DPP4 P27487 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ SLC28A1 O00337 1/20 0.38
▸ MAP3K7 O43318 1/20 0.38
▸ SLC28A2 O43868 1/20 0.38
▸ GAPDH P04406 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30515021 0.85 EGFR (0.53) EGFRERBB2ADORA2API4KAPI4K2B
SCHEMBL160359 0.85 EGFR (0.53) EGFRERBB2ADORA2API4KAPI4K2B
Niacinamide SCHEMBL8447045 0.84 EGFR (0.47) EGFRSRCKDRADORA2ANNMT
Phosphoric Acid SCHEMBL28300969 0.83 EGFR (0.48) EGFRERBB2ADORA2API4KAPI4K2B
Pyrimidine SCHEMBL27654880 0.79 PI4KA (0.50) EGFRERBB2ADORA2API4KAPI4K2B
SCHEMBL8859843 0.78 EGFR (0.48) EGFRSRCKDRADORA2API4KA
Niacinamide SCHEMBL28275359 0.77 EGFR (0.53) EGFRSRCKDRADORA2ANNMT
SCHEMBL16258664 0.76 PI4KA (0.55) EGFRERBB2ADORA2API4KAPI4K2B
SCHEMBL41360 0.76 PI4KA (0.55) EGFRERBB2ADORA2API4KAPI4K2B
SCHEMBL3794703 0.76 PI4KA (0.55) EGFRERBB2ADORA2API4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0824345-A4 S-ADENOSYL METHIONINE REGULATION OF METABOLIC PATHWAYS AND ITS USE IN DIAGNOSIS AND THERAPY ORIDIGM CORP (US) 1999-08-25 — — EP disclosed
EP-0824345-A1 S-ADENOSYL METHIONINE REGULATION OF METABOLIC PATHWAYS AND ITS USE IN DIAGNOSIS AND THERAPY ORIDIGM CORPORATION (US) 1998-02-25 — — EP disclosed
WO-1996033703-A2 S-ADENOSYL METHIONINE REGULATION OF METABOLIC PATHWAYS AND ITS USE IN DIAGNOSIS AND THERAPY ORIDIGM CORPORATION (US) 1996-10-31 — — WO disclosed
Send feedback